CIBC Innovation Banking Provides $7.5M of Growth Capital to SmartSkin Technologies Inc.

Audio By Carbonatix

FREDERICTON, New Brunswick--(BUSINESS WIRE)--Aug 6, 2025--

CIBC Innovation Banking announced today that it has provided a $7.5M facility in growth capital to SmartSkin Technologies, Inc. (SmartSkin), based in Atlantic Canada. The company will use the financing to expand its market reach.

SmartSkin delivers manufacturing intelligence solutions that empower pharmaceutical and beverage producers to optimize efficiency, ensure quality, and eliminate costly production issues. Its technology uses pressure-sensitive sensors and AI-driven analytics to provide global manufacturers with actionable data on the forces their containers experience during the filling, packaging and transporting process.

“This financing fuels our ambition to become the essential intelligence layer for pharmaceutical and beverage manufacturing,” said Evan Justason, CEO, SmartSkin. “We’re no longer just solving individual problems—we're building the digital foundation these industries will depend on to operate efficiently, safely, and with zero defects. With the trust of global leaders and a presence across every major market, SmartSkin is positioned to be not just a solution—but a standard. We’re grateful to the team at CIBC Innovation Banking for recognizing our vision and backing it with the kind of flexible, growth-oriented support that makes this next stage possible.”

“We are impressed by the flexibility of SmartSkin’s technology and its ability to proactively detect potential issues on production lines and precisely identify problems as they occur,” said Eric Laflamme, Managing Director, CIBC Innovation Banking. “We are proud to support the company in its growth journey.”

SmartSkin’s investors include the Business Development Bank of Canada, the New Brunswick Innovation Fund, East Valley and Schott Pharma.

About CIBC Innovation Banking

CIBC Innovation Banking has 25 years of specialized experience in growth-stage tech and life science companies across North America – a longer track record than most banks. CIBC Innovation Banking now has over $11 billion in funds managed including life sciences, health care, cleantech companies, investors, and entrepreneurs, and has assisted over 700 venture and private equity-backed businesses over the past six and a half years. The bank operates out of 14 global locations in San Francisco, Menlo Park, New York, Toronto, London, Austin, Boston, Chicago, Seattle, Vancouver, Montreal, Atlanta, Reston, and Durham. Connect with us today to start the conversation. Innovationbanking.cibc.com

About Smart Skin Technologies

SmartSkin Technologies delivers manufacturing intelligence solutions that empower pharmaceutical and beverage producers to optimize efficiency, ensure quality, and eliminate costly production issues. By combining advanced container twins with real-time analytics, SmartSkin helps manufacturers reduce waste, prevent defects, and drive continuous improvement across complex production lines. Trusted by global leaders like Schott, Pfizer, Sanofi, Coca-Cola, Heineken, and Kraft, SmartSkin ensures flawless execution and supports the industry's pursuit of zero-defect production.

View source version on businesswire.com:https://www.businesswire.com/news/home/20250806446680/en/

Katarina Milicevic,[email protected], 416-362-3458

KEYWORD: UNITED STATES NORTH AMERICA CANADA

INDUSTRY KEYWORD: TECHNOLOGY FINANCE VENTURE CAPITAL PACKAGING BANKING PROFESSIONAL SERVICES SOFTWARE MANUFACTURING DATA MANAGEMENT ARTIFICIAL INTELLIGENCE

SOURCE: CIBC Innovation Banking

Copyright Business Wire 2025.

PUB: 08/06/2025 07:00 AM/DISC: 08/06/2025 06:59 AM

http://www.businesswire.com/news/home/20250806446680/en